Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
BCMA-CD19 cCAR-T cell therapy (iCell Gene Therapeutics) in Inflammatory Bowel Diseases: NCT07544160 Clinical Landscape Report 2026
15 October 2026
NCT07544160 clinical landscape for Inflammatory Bowel Diseases: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
DISP-10 in Adenocarcinoma of large intestine: NCT07544589 Clinical Landscape Report 2026
15 October 2026
NCT07544589 clinical landscape for Adenocarcinoma of large intestine: endpoints, sponsor, phase, geography, readouts, asset context and development white spa…
9 min read
Atezolizumab in Unresectable Hepatocellular Carcinoma: NCT07543510 Clinical Landscape Report 2026
15 October 2026
NCT07543510 clinical landscape for Unresectable Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
Fludarabine Phosphate in Advanced Gastric Adenocarcinoma: NCT07551362 Clinical Landscape Report 2026
15 October 2026
NCT07551362 clinical landscape for Advanced Gastric Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Semaglutide (Novo Nordisk) in Diabetes Mellitus, Type 2: NCT07547878 Clinical Landscape Report 2026
15 October 2026
NCT07547878 clinical landscape for Diabetes Mellitus, Type 2: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
HH-009 in FGFR4 positive Neoplasms: NCT07547553 Clinical Landscape Report 2026
15 October 2026
NCT07547553 clinical landscape for FGFR4 positive Neoplasms: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Pitavastatin Sodium in Pancreatic carcinoma non-resectable: NCT07549958 Clinical Landscape Report 2026
15 October 2026
NCT07549958 clinical landscape for Pancreatic carcinoma non-resectable: endpoints, sponsor, phase, geography, readouts, asset context and development white s…
9 min read
Upadacitinib hemihydrate in Colitis, Ulcerative: NCT07550673 Clinical Landscape Report 2026
15 October 2026
NCT07550673 clinical landscape for Colitis, Ulcerative: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
NN-001 in Primary Parkinson's disease: NCT07550374 Clinical Landscape Report 2026
15 October 2026
NCT07550374 clinical landscape for Primary Parkinson's disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Cetuximab in Locally Advanced Malignant Solid Neoplasm: NCT07551778 Clinical Landscape Report 2026
15 October 2026
NCT07551778 clinical landscape for Locally Advanced Malignant Solid Neoplasm: endpoints, sponsor, phase, geography, readouts, asset context and development w…
9 min read
Paclitaxel in Advanced gastric carcinoma: NCT07552402 Clinical Landscape Report 2026
15 October 2026
NCT07552402 clinical landscape for Advanced gastric carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
CAR-M-c-MET(Peking Union Medical College, Chinese Academy of Medical Sciences) in Advanced Pancreatic Adenocarcinoma: NCT07553793 Clinical Landscape Report 2026
15 October 2026
NCT07553793 clinical landscape for Advanced Pancreatic Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white sp…